Arrowstreet Capital
AGIO icon

Arrowstreet Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Arrowstreet Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.2M Sell
608,876
-201,654
-25% -$7.05M 0.01% 810
2026
Q2 		$30.1M Buy
810,530
+560,069
+224% +$17M 0.01% 726
2026
Q1 		$8.47M Buy
+250,461
New +$7.1M ﹤0.01% 997
2015
Q3 		– Sell
-6,300
Closed -$700K – 1329
2015
Q2 		$700K Sell
6,300
-4,800
-43% -$517K ﹤0.01% 908
2015
Q1 		$1.05M Buy
+11,100
New +$1.24M 0.01% 707

Other funds holding AGIO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Arrowstreet Capital's AGIO Position: Q3 2026 in Review

Arrowstreet Capital reduced its Agios Pharmaceuticals (AGIO) stake by 25% in Q3 2026, selling an estimated $7.05M and leaving 608,876 shares worth $20.2M. The position accounts for 0.01% of the portfolio, ranked #810.

Arrowstreet Capital first reported a position in AGIO in Q1 2015 and has held it in 5 quarters since. The position peaked at $30.1M in Q2 2026. 175 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • Arrowstreet Capital held 608,876 shares of Agios Pharmaceuticals worth $20.2M as of Q3 2026.
  • Arrowstreet Capital sold 201,654 Agios Pharmaceuticals shares in Q3 2026, an estimated $7.05M.
  • Agios Pharmaceuticals made up 0.01% of Arrowstreet Capital's portfolio in Q3 2026, its #810 holding.
  • Arrowstreet Capital first reported a position in Agios Pharmaceuticals in Q1 2015 and has held it in 5 quarters since.
  • Arrowstreet Capital's Agios Pharmaceuticals position peaked at $30.1M in Q2 2026.
  • 175 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Arrowstreet Capital's 13F filing for Q3 2026, filed 13 Nov 2026.